If you're not discussing your pancreatic cancer patients in multidisciplinary fashion you are under-serving them

Tumor boards optimize outcomes#pancsm #GDUGI2021 #medtwitter

— Mark Lewis (@marklewismd) May 7, 2021

Bacteria, #cancer & #immunotherapy efficacy: a window for new therapeutic opportunities. Intra-tumoral bacteria can directly modulate antitumor immune responses; this represents a new class of therapeutically relevant, non-human tumor antigens.https://t.co/cqKe3VEzJz pic.twitter.com/qobCk5yVKM

— soria (@jsoriamd) May 12, 2021

Here is an open access link to read/download our #VTE Seminar! https://t.co/dJFM8ea0NT@TritschlerMD @SusanRKahn1 @RodgerMarc https://t.co/hIgeVtVBSw

— Faizan Khan (@FaizanK91) May 12, 2021

Immune Checkpoint Inhibitors and Thrombosis:

Key points from this article include that cancer patients treated with checkpoint inhibitors are at significant increased risk of VTE/ATEhttps://t.co/W3dUeSTD7c pic.twitter.com/xPMUOyhlm5

— David Henry (@davidhenrymd) May 13, 2021

ICYMI: How can health care practitioners support the decisions of #breastcancer patients? Find out my thoughts in an article featuring Dr. @margenthalerj of @SitemanCenter in @ClinOncNews: https://t.co/RPIFzkS6mN #patientcenteredcare #bcsm #lumpectomy #mastectomy https://t.co/a3dzVGveqI

— AnanthRavi (@AnanthRaviMCCPM) May 13, 2021